g plan semaglutide Glucagon-like peptide-1 (GLP-1) receptor agonists (semaglutide [Wegovy, Ozempic, Rybelsus]) and dual incretin agonists (tirzepatide [Zepbound, Mounjaro]) are medications that reduce food cravings, increase fullness, slow digestion, and can help control Compound Semaglutide

doi:10.1056/NEJMoa160714 Reserved Perkovic V, Tuttle KR, Rossing P, et al

If youre prescribed laxatives, be sure to discuss risks and drug interactions with your provider

Cost and Coverage: Check with your insurance provider to see which medication is covered and explore potential savings programs for either drug

Marcus Harris, who works as a Waffle House cook, needs Trulicity to keep his legs and feet from swelling and bruising

Do not take a double dose to make up for the missed dose

When used alongside a reduced-calorie diet and increased physical activity, Wegovy has been shown to help patients lose up to 1921% of their body weight over 72 weeks (7.2mg dose) or around 1517% over 68 weeks at the standard 2.4mg dose [1]